Sumitomo Mitsui Trust Group’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$43.1M Sell
476,834
-43,614
-8% -$4M 0.03% 483
2025
Q4
$46.8M Buy
520,448
+8,000
+2% +$759K 0.03% 483
2025
Q3
$50.5M Buy
512,448
+5,416
+1% +$537K 0.03% 471
2025
Q2
$46.2M Buy
507,032
+5,317
+1% +$514K 0.03% 471
2025
Q1
$56.8M Sell
501,715
-2,647
-0.5% -$283K 0.04% 409
2024
Q4
$53.3M Buy
504,362
+22,396
+5% +$2.4M 0.04% 430
2024
Q3
$52M Sell
481,966
-5,117
-1% -$558K 0.04% 441
2024
Q2
$52.9M Sell
487,083
-8,910
-2% -$1.05M 0.04% 406
2024
Q1
$65.5M Buy
495,993
+753
+0.2% +$94.1K 0.04% 417
2023
Q4
$60.3M Sell
495,240
-52,239
-10% -$5.83M 0.04% 424
2023
Q3
$61.4M Buy
547,479
+32,557
+6% +$4.13M 0.05% 384
2023
Q2
$75M Sell
514,922
-68,087
-12% -$9.25M 0.06% 359
2023
Q1
$75.3M Sell
583,009
-3,284
-0.6% -$412K 0.06% 373
2022
Q4
$74.8M Sell
586,293
-1,908
-0.3% -$221K 0.06% 371
2022
Q3
$61.5M Sell
588,201
-2,144
-0.4% -$235K 0.05% 417
2022
Q2
$62M Sell
590,345
-16,399
-3% -$1.95M 0.05% 428
2022
Q1
$77.6M Sell
606,744
-188,233
-24% -$22.7M 0.05% 393
2021
Q4
$98.1M Buy
794,977
+178,138
+29% +$23.3M 0.06% 344
2021
Q3
$87.7M Sell
616,839
-121,472
-16% -$17.9M 0.05% 376
2021
Q2
$115M Sell
738,311
-100,483
-12% -$16.3M 0.07% 319
2021
Q1
$130M Buy
838,794
+1,325
+0.2% +$205K 0.08% 276
2020
Q4
$125M Buy
837,469
+39,203
+5% +$5.54M 0.08% 279
2020
Q3
$106M Sell
798,266
-62,424
-7% -$8.15M 0.07% 293
2020
Q2
$99.7M Sell
860,690
-1,536
-0.2% -$177K 0.07% 298
2020
Q1
$84.6M Buy
862,226
+40,987
+5% +$5.37M 0.07% 296
2019
Q4
$119M Sell
821,239
-5,977
-0.7% -$825K 0.09% 226
2019
Q3
$110M Buy
827,216
+16,646
+2% +$2.15M 0.1% 236
2019
Q2
$92.7M Buy
810,570
+19,716
+2% +$2.31M 0.08% 257
2019
Q1
$98M Buy
790,854
+12,976
+2% +$1.47M 0.09% 238
2018
Q4
$77.5M Buy
777,878
+127,321
+20% +$14.3M 0.08% 252
2018
Q3
$83M Buy
650,557
+13,534
+2% +$1.61M 0.09% 246
2018
Q2
$68.9M Buy
637,023
+37,064
+6% +$4.03M 0.08% 272
2018
Q1
$63.5M Sell
599,959
-61,897
-9% -$7.19M 0.08% 273
2017
Q4
$77.5M Buy
661,856
+5,740
+0.9% +$649K 0.1% 222
2017
Q3
$74.6M Buy
656,116
+66,182
+11% +$7.64M 0.11% 209
2017
Q2
$73.5M Sell
589,934
-1,009
-0.2% -$120K 0.11% 216
2017
Q1
$70.1M Sell
590,943
-4,877
-0.8% -$553K 0.11% 221
2016
Q4
$59.7M Buy
595,820
+10,704
+2% +$1.15M 0.1% 242
2016
Q3
$73.9M Buy
585,116
+8,090
+1% +$1,000K 0.12% 204
2016
Q2
$67.4M Buy
577,026
+25,456
+5% +$2.88M 0.12% 211
2016
Q1
$57.1M Buy
551,570
+12,820
+2% +$1.24M 0.1% 237
2015
Q4
$53.6M Sell
538,750
-652
-0.1% -$63.8K 0.1% 241
2015
Q3
$49.2M Buy
539,402
+81,397
+18% +$8.16M 0.1% 248
2015
Q2
$48.6M Buy
458,005
+8,945
+2% +$990K 0.09% 268
2015
Q1
$51.2M Buy
449,060
+40,856
+10% +$4.66M 0.09% 263
2014
Q4
$45.4M Sell
408,204
-10,515
-3% -$1.11M 0.09% 268
2014
Q3
$40.9M Buy
418,719
+422
+0.1% +$41.5K 0.08% 286
2014
Q2
$42.2M Sell
418,297
-12,102
-3% -$1.18M 0.09% 265
2014
Q1
$39.5M Sell
430,399
-9,717
-2% -$896K 0.08% 280
2013
Q4
$39.8M Sell
440,116
-22,084
-5% -$1.91M 0.08% 282
2013
Q3
$36.9M Sell
462,200
-16,196
-3% -$1.27M 0.08% 299
2013
Q2
$34.8M Buy
+478,396
New +$35.8M 0.08% 292

Other funds holding ZBH

Sumitomo Mitsui Trust Group's ZBH Position: Q1 2026 in Review

Sumitomo Mitsui Trust Group reduced its Zimmer Biomet (ZBH) stake by 8.4% in Q1 2026, selling an estimated $4M and leaving 476,834 shares worth $43.1M. The position accounts for 0.03% of the portfolio, ranked #483.

Sumitomo Mitsui Trust Group first reported a position in ZBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $130M in Q1 2021. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Sumitomo Mitsui Trust Group held 476,834 shares of Zimmer Biomet worth $43.1M as of Q1 2026.
  • Sumitomo Mitsui Trust Group sold 43,614 Zimmer Biomet shares in Q1 2026, an estimated $4M.
  • Zimmer Biomet made up 0.03% of Sumitomo Mitsui Trust Group's portfolio in Q1 2026, its #483 holding.
  • Sumitomo Mitsui Trust Group first reported a position in Zimmer Biomet in Q2 2013 and has held it in 52 quarters since.
  • Sumitomo Mitsui Trust Group's Zimmer Biomet position peaked at $130M in Q1 2021.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q1 2026, filed 30 Apr 2026.